Abstract
Abnormalities in cellular differentiation are frequent occurrences in human cancers. Treatment of human melanoma cells with recombinant fibroblast interferon (IFN-β) and the protein kinase C activator mezerein (MEZ) results in an irreversible loss in growth potential, suppression of tumorigenic properties and induction of terminal cell differentiation. Subtraction hybridization identified melanoma differentiation associated gene-7 (mda-7), as a gene induced during these physiological changes in human melanoma cells. Ectopic expression of mda-7 by means of a replication defective adenovirus results in growth suppression and induction of apoptosis in a broad spectrum of additional cancers, including melanoma, glioblastoma multiforme, osteosarcoma and carcinomas of the breast, cervix, colon, lung, nasopharynx and prostate. In contrast, no apparent harmful effects occur when mda-7 is expressed in normal epithelial or fibroblast cells. Human clones of mda-7 were isolated and its organization resolved in terms of intron/exon structure and chromosomal localization. Hu-mda-7 encompasses seven exons and six introns and encodes a protein with a predicted size of 23.8 kDa, consisting of 206 amino acids. Hu-mda-7 mRNA is stably expressed in the thymus, spleen and peripheral blood leukocytes. De novo mda-7 mRNA expression is also detected in human melanocytes and expression is inducible in cells of melanocyte/melanoma lineage and in certain normal and cancer cell types following treatment with a combination of IFN-β plus MEZ. Mda-7 expression is also induced during megakaryocyte differentiation induced in human hematopoietic cells by treatment with TPA (12-O-tetradecanoyl phorbol-13-acetate). In contrast, de novo expression of mda-7 is not detected nor is it inducible by IFN-β+MEZ in a spectrum of additional normal and cancer cells. No correlation was observed between induction of mda-7 mRNA expression and growth suppression following treatment with IFN-β+MEZ and induction of endogenous mda-7 mRNA by combination treatment did not result in significant intracellular MDA-7 protein. Radiation hybrid mapping assigned the mda-7 gene to human chromosome 1q, at 1q 32.2 to 1q41, an area containing a cluster of genes associated with the IL-10 family of cytokines. Mda-7 represents a differentiation, growth and apoptosis associated gene with potential utility for the gene-based therapy of diverse human cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alitalo R . 1990 Leuk. Res. 14: 501–514
Armstrong BK, Kricker A . 1994 Cancer Surv. 19/20: 219–240
Bishop JM . 1991 Cell 64: 235–248
Blumberg H, Conklin D, Xu W, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman B, Hammond A, Haughen H, Jelinek L, Kelly J, Madden K, Maurer M, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore T, Yao L, Kuechle M, Dale B, Chandrasekher Y . 2001 Cell 104: 9–19
Breathnach R, Benoist C, O'Hare K, Gannon F, Chambon P . 1978 Proc. Natl. Acad. Sci. USA 75: 4853–4857
Breathnach R, Chambon P . 1981 Annu. Rev. Biochem. 50: 349–383
Chaiken IM, Williams WV . 1996 Trends Biotechnol. 14: 369–375
Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM . 1999 Cell Tissue Res. 296: 331–337
Clark W . 1991 Br. J. Cancer 64: 631–644
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM . 1996 Nat. Genet. 14: 457–460
Falck-Pedersen E, Heinflink M, Alvira M, Nussenzveig DR, Gershengorn MC . 1994 Mol. Pharmacol. 45: 684–689
Fisher PB . 1984 Tumor Promotion and Cocarcinogenesis In Vitro, Mechanisms of Tumor Promotion. Slaga TJ (ed) CRC Press Inc.: Boca Raton, Florida pp. 57–83
Fisher PB, Prignoli DR, Hermo Jr H, Weinstein IB, Pestka S . 1985 J. Interferon Res. 5: 11–22
Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vasquez N, Pestka S, Donnelly RP, Kotenko SV . 2000 Genes Immun. 1: 442–450
Graham FL, Smiley J, Russell WC, Nairn R . 1977 J. Gen. Virol. 36: 59–72
Graham GM, Guarini L, Moulton TA, Datta S, Ferrone S, Giacomini P, Kerbel RS, Fisher PB . 1991 Cancer Immunol. Immunotherap. 32: 382–390
Guarini L, Temponi M, Bruce JN, Bollon AP, Duigou GJ, Moulton TA, Ferrone S, Fisher PB . 1990 Intl. J. Cancer 46: 1041–1047
Herlyn M, Berking C, Li G, Satyamoorthy K . 2000 Melanoma Res. 10: 303–312
Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB . 1999a Oncogene 18: 3546–3552
Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB . 1999b Gene 236: 125–131
Jiang H, Fisher PB . 1993 Mol. Cell. Differ. 1: 285–299
Jiang H, Kang D-C, Alexandre D, Fisher PB . 2000 Proc. Natl. Acad. Sci. USA 93: 9160–9165
Jiang H, Lin J, Fisher PB . 1994 Mol. Cell. Differ. 2: 221–239
Jiang H, Lin JJ, Su Z-Z, Goldstein NI, Fisher PB . 1995b Oncogene 11: 2477–2486
Jiang H, Lin J, Su Z-Z, Kerbel RS, Herlyn M, Weissman RB, Welch D, Fisher PB . 1995a Oncogene 10: 1855–1864
Jiang H, Su Z-Z, Boyd J, Fisher PB . 1993 Mol. Cell. Differ. 1: 41–66
Jiang H, Su Z-Z, Lin JJ, Goldstein NI, Young CSH, Fisher PB . 1996 Proc. Natl. Acad. Sci. USA 93: 9160–9165
Kang D-C, Jiang H, Wu Q, Pestka S, Fisher PB . 2001 Gene 267: 233–242
Kang D-C, LaFrance R, Su Z-Z, Fisher PB . 1998 Proc. Natl. Acad. Sci. USA 95: 13788–13793
Kerbel RS, Man MS . 1984 Invasion Metastasis 4: Suppl 1 31–43
Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S . 2001 J. Biol. Chem. 276: 2725–2732
Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB . 2001 Pharmacol. Therapeut in press
Li DQ, Lee SB, Tseng SC . 1999 Curr. Eye Res. 19: 154–161
Madireddi MT, Dent P, Fisher PB . 2000a Oncogene 19: 1362–1368
Madireddi MT, Dent P, Fisher PB . 2000b J. Cell. Physiol. 185: 36–46
Madireddi MT, Su Z-Z, Young CSH, Goldstein NI, Fisher PB . 2000c Adv. Exptl. Med. Biol. 465: 239–261
McGrory WJ, Bautista DS, Graham FL . 1988 Virology 163: 614–617
Mhashilkar AB, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S . 2001 Mol. Med. 7: 271–282
Miller MS . 1999 J. Foot Ankle Surg. 38: 227–231
Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO . 2000 Nat. Genet. 24: 227–235
Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R . 2000 Gene Therapy 7: 2051–2057
Saito I . 2000 Crit. Rev. Immunol. 20: 153–165
Sambrook J, Fritsch EF, Maniatis T . 1989 Cold Spring Harbor Laboratory Press, 2nd ed Cold Spring Harbor, NY
Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW . 1996 Proc. Natl. Acad. Sci. USA 93: 10614–10619
Soo C, Shaw WW, Freymiller E, Longaker MT, Bertolami CN, Chiu R, Tieu A, Ting K . 1999 J. Cell. Biochem. 74: 1–10
Su Z-Z, Goldstein NI, Jiang H, Wang M-N, Duigou GJ, Young CSH, Fisher PB . 1999 Proc. Natl. Acad. Sci. USA 96: 15115–15120
Su Z-Z, Madireddi MT, Lin JJ, Young CSH, Kitada S, Reed JC, Goldstein NI, Fisher PB . 1998 Proc. Natl. Acad. Sci. USA 95: 14400–14405
Su Z-Z, Shi Y, Fisher PB . 1997 Proc. Natl. Acad. Sci. USA 94: 9125–9130
Su Z-Z, Yemul S, Estabrook A, Zimmer SG, Friedman RM, Fisher PB . 1995 Intl. J. Oncology 7: 1279–1284
Tonetti DA, Horio M, Collart FR, Huberman E . 1992 Cell Growth Differ. 3: 739–745
Vita JR, Edwalds GM, Gorey T, Housepian EM, Fetell MR, Guarini L, Langer JA, Fisher PB . 1988 Anticancer Res. 8: 297–302
Vogelstein B, Kinzler KW . 1991 Trends Genet. 9: 138–141
Volkert FC, Young CSH . 1983 Virology 125: 175–193
Waxman S . 1996 Differentiation Therapy. Waxman S (ed) Serono Symposium Publications, Rome, Italy pp. 1–528
Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL . 2000 J. Biol. Chem. 275: 31335–31339
Zhang R, Tan Z, Liang P . 2000 J. Biol. Chem. 275: 24436–24443
Acknowledgements
This study was supported in part by National Institutes of Health grant CA35675, CA80826, Columbia Skin Diseases Research Center (P30-AR44535), the Samuel Waxman Cancer Research Foundation, the Chernow Endowment and Introgen Therapeutics, Inc. MT Madireddi was supported by a fellowship award from the Army Department of Defense Initiative on Breast Cancer (DAMD17-98-1-8053). PB Fisher is the Michael and Stella Chernow Urological Cancer Research Scientist in the Departments of Neurosurgery, Pathology and Urology. We thank Drs Theresa Druck and Kay Hubner for assistance with the chromosomal mapping of mda-7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, E., Madireddi, M., Gopalkrishnan, R. et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20, 7051–7063 (2001). https://doi.org/10.1038/sj.onc.1204897
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204897
Keywords
This article is cited by
-
Expression, Purification, and Polyethylene Glycol Site-Specific Modification of Recombinant Human Interleukin 24 in Escherichia coli
The Protein Journal (2019)
-
Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with/without TNF-alpha
Scientific Reports (2018)
-
MDA7/IL-24 is an anti-viral factor that inhibits influenza virus replication
Journal of Microbiology (2016)
-
Apoptotic signal pathways and regulatory mechanisms of cancer cells induced by IL-24
Wuhan University Journal of Natural Sciences (2016)
-
Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities
Journal of Molecular Signaling (2013)